Insider · CIK 0001846086
William Tober Abraham
Files at SCPH (scPharmaceuticals Inc.). First filing -, latest -.
In brief
William Tober Abraham files SEC Form 4 as director at SCPH (scPharmaceuticals Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; William Tober Abraham has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,750 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,300 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Jun 3, 2025 | SCPH scPharmaceuticals Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 5, 2025 |
Questions about William Tober Abraham
Answered from the filings on this page, as of the latest one.
Is William Tober Abraham buying or selling?
William Tober Abraham has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did William Tober Abraham's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William Tober Abraham has 0.
Where does William Tober Abraham file Form 4?
William Tober Abraham has filed Form 4 at SCPH (scPharmaceuticals Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.